Skip to main content

Table 1 Patient and treatment characteristics

From: The technical feasibility of an image-guided intensity-modulated radiotherapy (IG-IMRT) to perform a hypofractionated schedule in terms of toxicity and local control for patients with locally advanced or recurrent pancreatic cancer

No.

Sex

Age

Site

Stage

RT

Chemotherapy

Local response

Site of failure

TTP (months)

Survival (months)

     

Dose (Gy/Fxs)

CCRT

After CCRT

    

1

M

42

Head

T4N1

50/20

5-FU

GEM

SD

Distant

7.6

12.1*

2

M

64

Head

T4N0

50/20

5-FU

GEM

PR

  

7.6*

3

M

72

RM

Recurrent

50/20

5-FU

GEM

SD

Distant

7.9

26.0*

4

F

61

Head

T4N0

50/20

5-FU

GEM

PR

  

7.2*

5

M

74

Body

T4N0

50/20

5-FU

GEM

SD

Distant

2.0

9.8*

6

M

63

Tail

T4N0

50/20

5-FU

GEM

PR

Distant

6.0

9.2*

7

F

61

Celiac trunk

Recurrent

50/20

5-FU

5-FU/LV

PR

Distant

8.0

12.8*

8

M

66

Body

T4N1

50/20

5-FU

 

SD

Local/Distant

14.6

22.7*

9

M

71

Body

T4N0

50/20

5-FU

GEM

PR

Distant

13.9

19.4*

10

M

68

Head

T4N0

45/15

5-FU

GEM

PR

Distant

8.0

20.0*

11

F

56

Celiac trunk

Recurrent

45/15

5-FU

GEM

PR

Distant

4.9

6.9

12

F

66

Head

T4N1

45/15

5-FU

GEM

SD

  

5.7

  1. Abbreviations: RT = radiotherapy; CCRT = concurrent chemoradiation; GEM = gemcitabine; 5-FU = 5-fluorouracil; LV = leucovorin; TTP = time to progression; PR = partial regression; SD = stable disease; RM = resection margin.
  2. * Dead.
  3. Recurrent disease after curative resection.